Exelixis (NASDAQ:EXEL) Stock Price Expected to Rise, JMP Securities Analyst Says
Exelixis (NASDAQ:EXEL – Get Free Report) had its price target increased by investment analysts at JMP Securities from $47.00 to $50.00 in a report issued on Monday,Benzinga reports. The firm currently has a “market outperform” rating on the biotechnology company’s stock. JMP Securities’ price objective would indicate a potential upside of 9.36% from the stock’s […]
Exelixis (NASDAQ:EXEL – Get Free Report) had its price target increased by investment analysts at JMP Securities from $47.00 to $50.00 in a report issued on Monday,Benzinga reports. The firm currently has a “market outperform” rating on the biotechnology company’s stock. JMP Securities’ price objective would indicate a potential upside of 9.36% from the stock’s […]
